The article Key Takeaways from MindMed’s 2023 Corporate Update was originally published on Microdose. On January 9th, psychedelic medicine company MindMed (Nasdaq:...
Pat Burke will introduce legislation to legalize psychedelic-assisted therapy following Linda Rosenthal’s bill to legalize possession of psychedelic...
MAPS Public Benefit Corporation, a private biopharmaceutical company dedicated to the development and commercialization of psychedelic medicines, announced...
It seems it is business as usual for Mind Medicine, aka MindMed, (NASDAQ: MNMD) as the firm gave updates on The post MindMed Expects Results For...
State Senator Scott Wiener's bill picks up where last year's bill left off, but does not include synthetic substances like MDMA and LSD. The post Newly...
With all the twists and turns coming from the U.S. federal government, decriminalization and legalization of psychedelics advancing all across the country,...
The article 2022 End-of-Year Review: MindMed was originally published on Microdose. Continuing our series of 2022 end-of-year reviews, we take a look...
How do you measure a year? Time? Worldly events? Personal growth? There are many things that you could measure the time of the year against. Here...
The article 2022 Review: 3 Trials Pushing Boundaries of Psychedelic Medicine was originally published on Microdose. In my most recent article, The Top...
From a new congressional caucus to the protection of indigenous knowledge, leaders in the field reflect on this year's significant events in the psychedelic...